ライフサイエンスコーパス: killer immunoglobulin-like receptor

1 mat, and cell surface receptors, such as the killer immunoglobulin-like receptors.

2 pecifically downregulates disease-associated killer immunoglobulin-like receptors.

3 munoreceptors such as the T cell receptor or killer immunoglobulin-like receptors.

4 els of the activating receptor NKp46 and the killer immunoglobulin-like receptors 2DL1/S1 and 3DL1, r

5 cytolytic function associated with decreased killer immunoglobulin-like receptor 3DL1 expression.

6 CD117(+)M-CSFR(+)) showed more expression of killer immunoglobulin-like receptors, a fraction of kill

7 tural killer (NK) cells and their activating killer immunoglobulin-like receptors (aKIRs) influence t

8 rtain the association of natural killer cell killer immunoglobulin-like receptors and human leukocyte

9 ike receptors, mannose-binding lectin, CD14, killer immunoglobulin-like receptors, and matrix metallo

10 e-binding positions 9, 99, 116, and 156, and killer immunoglobulin-like receptor binding position 77

11 This study demonstrates that activating killer immunoglobulin-like receptors can recruit NK cell

12 sion is closely monitored by NK cells, whose killer immunoglobulin-like receptors encode MHC-I-specif

13 ng patients (n=222) and controls (n=191) for killer immunoglobulin-like receptor gene polymorphisms d

14 tor-ligand interactions (for example, due to killer immunoglobulin-like receptor-HLA mismatch) can tr

15 g/m(2)/d on days -6 through -2), followed by killer immunoglobulin-like receptor-human leukocyte anti

16 regard, NK cells that express an inhibitory killer immunoglobulin-like receptor (iKIR) for which the

17 he role of education through four inhibitory killer immunoglobulin-like receptors (iKIRs) from person

18 In some cases, such as killer immunoglobulin-like receptors, immune receptors a

19 ating natural killer (NK) cell receptor, the killer immunoglobulin-like receptor (KIR) 3DS1, and its

20 ells expressing CD94: NKG2A but no change in killer immunoglobulin-like receptor (KIR) expression.

21 d 0.7 to 21 years were enrolled; donors were killer immunoglobulin-like receptor (KIR) favorable base

22 The killer immunoglobulin-like receptor (KIR) gene cluster s

23 in reaction (PCR) assays to compare NKG2 and killer immunoglobulin-like receptor (KIR) gene expressio

24 Killer immunoglobulin-like receptor (KIR) genes on NK ce

25 -cells played by the inherited repertoire of killer immunoglobulin-like receptor (KIR) genes therefor

26 Killer immunoglobulin-like receptor (KIR) genes vary con

27 atural killer (NK) receptors, in particular, killer immunoglobulin-like receptor (KIR) KIR3DL2, a rec

28 ent MHC class I ligands for donor inhibitory killer immunoglobulin-like receptor (KIR) receptors, as

29 Killer immunoglobulin-like receptor (KIR) recognition of

30 Several studies support a role for specific killer immunoglobulin-like receptor (KIR)-HLA combinatio

31 We used expanded human NK cells from killer immunoglobulin-like receptor (KIR)/HLA-genotyped

32 Furthermore, killer immunoglobulin-like receptor (KIR)/KIR-ligand mis

33 " In humans, interactions between inhibitory killer immunoglobulin-like receptors (KIR) and human MHC

34 Killer immunoglobulin-like receptors (KIR) are expressed

35 Killer immunoglobulin-like receptors (KIR) bind self-maj

36 een HLA-B27 and immune receptors such as the killer immunoglobulin-like receptors (KIR) found on a ra

37 We assessed the value of killer immunoglobulin-like receptor(KIR) phenotyping and

38 are transmitted by NK inhibitory receptors (killer immunoglobulin-like receptors, KIR) at the site o

39 Interactions between killer immunoglobulin-like receptors (KIRs) and human le

40 ct to two such families of NK receptors, the killer immunoglobulin-like receptors (KIRs) and the kill

41 inhibitory receptors, such as the family of killer immunoglobulin-like receptors (KIRs) and the NKG2

42 Killer immunoglobulin-like receptors (KIRs) are a family

43 I molecules as ligands to NK cell inhibitory killer immunoglobulin-like receptors (KIRs) as a means o

44 Killer immunoglobulin-like receptors (KIRs) bind human l

45 city is attenuated by ligation of inhibitory killer immunoglobulin-like receptors (KIRs) by HLA class

46 portant role of NK cells expressing specific killer immunoglobulin-like receptors (KIRs) in the contr

47 Cellular inactivation through killer immunoglobulin-like receptors (KIRs) may allow ne

48 Killer immunoglobulin-like receptors (KIRs) on natural k

49 argely been attributed to mismatches between killer immunoglobulin-like receptors (KIRs) on NK cells

50 Receptors termed killer immunoglobulin-like receptors (KIRs) on NK cells

51 The killer immunoglobulin-like receptors (KIRs) on NK cells

52 Killer immunoglobulin-like receptors (KIRs) play an esse

53 Killer immunoglobulin-like receptors (KIRs) regulate cel

54 Killer immunoglobulin-like receptors (KIRs) regulate nat

55 ansplantation, produce cytokines and express killer immunoglobulin-like receptors (KIRs) that regulat

56 h increasing age, T cells gain expression of killer immunoglobulin-like receptors (KIRs) that transmi

57 ortant ligands for inhibitory and activating killer immunoglobulin-like receptors (KIRs) which are fo

58 Instead, CD4(+)CD28(null) T cells express killer immunoglobulin-like receptors (KIRs) with a prefe

59 ors, including the activating and inhibitory killer immunoglobulin-like receptors (KIRs), and human l

60 tural killer (NK) cells possess little or no killer immunoglobulin-like receptors (KIRs), high interf

61 ell checkpoint inhibitor, targets inhibitory killer immunoglobulin-like receptors (KIRs), however it

62 cted cells by both activating and inhibitory killer immunoglobulin-like receptors (KIRs).

63 ler (NK) cells and these share expression of killer immunoglobulin-like receptors (KIRs).

64 yndromes (ACS), CD4+CD28null T cells express killer immunoglobulin-like receptors (KIRs).

65 ulations that clonally expressed one or more killer immunoglobulin-like receptors (KIRs).

66 s and a chemokine-like protein that binds to killer immunoglobulin-like receptors (KIRs).

67 ic factors for improved outcome were missing killer immunoglobulin-like receptor ligand (PFS and OS),

68 ng CBRM1/5-positive granulocytes and missing killer immunoglobulin-like receptor ligand as positive i

69 When the model for OS also included missing killer immunoglobulin-like receptor ligand, human antimo

70 Stimulatory killer immunoglobulin-like receptors, NKG2D and stimulat

71 cell-surface dimers that can activate innate killer immunoglobulin-like receptors on CD4(+) T helper

72 Since Cw*04 is a ligand for the killer immunoglobulin-like receptors on natural killer c

73 immunoglobulin-like receptors, a fraction of killer immunoglobulin-like receptor-positive-expressing